Taysha Gene Therapies (TSHA) Amortizatization of Intangibles (2022 - 2026)

Taysha Gene Therapies has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $285000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $285000.0, down 15.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 6.01% YoY), and the FY2025 annual result was $1.4 million, up 11.67% from the prior year.
• Amortizatization of Intangibles came in at $285000.0 for Q1 2026 at Taysha Gene Therapies, down from $400000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $400000.0 in Q4 2025 to a low of $274000.0 in Q4 2023.
• The 5-year median for Amortizatization of Intangibles is $305000.0 (2023), against an average of $315176.5.
• Across the five-year window, Amortizatization of Intangibles declined 20.78% in 2023 and surged 32.89% in 2025, its largest moves.
• Taysha Gene Therapies' Amortizatization of Intangibles stood at $284000.0 in 2022, then slipped by 3.52% to $274000.0 in 2023, then increased by 9.85% to $301000.0 in 2024, then soared by 32.89% to $400000.0 in 2025, then fell by 28.75% to $285000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $285000.0 (Q1 2026), $400000.0 (Q4 2025), and $312000.0 (Q3 2025), per Business Quant data.